1
|
Wu RQ, Zhao XF, Wang ZY, Zhou M and Chen
QM: Novel molecular events in oral carcinogenesis via integrative
approaches. J Dent Res. 90:561–572. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Scully C and Bagan JV: Recent advances in
oral oncology 2008; squamous cell carcinoma imaging, treatment,
prognostication and treatment outcomes. Oral Oncol. 45:e25–e30.
2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Rusthoven K, Ballonoff A, Raben D and Chen
C: Poor prognosis in patients with stage I and II oral tongue
squamous cell carcinoma. Cancer. 112:345–351. 2008. View Article : Google Scholar : PubMed/NCBI
|
4
|
Perrin BJ and Huttenlocher A: Calpain. Int
J Biochem Cell Biol. 34:722–725. 2002. View Article : Google Scholar : PubMed/NCBI
|
5
|
Goll DE, Thompson VF, Li H, Wei W and Cong
J: The calpain system. Physiol Rev. 83:731–801. 2003. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ono Y and Sorimachi H: Calpains: An
elaborate proteolytic system. Biochim Biophys Acta. 1824:224–236.
2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Croall DE and Ersfeld K: The calpains:
Modular designs and functional diversity. Genome Biol. 8:2182007.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Storr SJ, Carragher NO, Frame MC, Parr T
and Martin SG: The calpain system and cancer. Nat Rev Cancer.
11:364–374. 2011. View
Article : Google Scholar : PubMed/NCBI
|
9
|
Storr SJ, Woolston CM, Barros FF, Green
AR, Shehata M, Chan SY, Ellis IO and Martin SG: Calpain-1
expression is associated with relapse-free survival in breast
cancer patients treated with trastuzumab following adjuvant
chemotherapy. Int J Cancer. 129:1773–1780. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Storr SJ, Mohammed RA, Woolston CM, Green
AR, Parr T, Spiteri I, Caldas C, Ball GR, Ellis IO and Martin SG:
Calpastatin is associated with lymphovascular invasion in breast
cancer. Breast. 20:413–418. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Storr SJ, Safuan S, Woolston CM,
Abdel-Fatah T, Deen S, Chan SY and Martin SG: Calpain-2 expression
is associated with response to platinum based chemotherapy,
progression-free and overall survival in ovarian cancer. J Cell Mol
Med. 16:2422–2428. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Storr SJ, Pu X, Davis J, Lobo D,
Reece-Smith AM, Parsons SL, Madhusudan S and Martin SG: Expression
of the calpain system is associated with poor clinical outcome in
gastro-oesophageal adenocarcinomas. J Gastroenterol. 48:1213–1221.
2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Salehin D, Fromberg I, Haugk C, Dohmen B,
Georg T, Bohle RM, Bauerschlag D, Maass N and Friedrich M:
Immunhistochemical analysis for expression of calpain1, calpain 2
and calpastatin in endometrial cancer. Anticancer Res.
30:2837–2843. 2010.PubMed/NCBI
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Hamilton SR and Aaltonen LA: World Health
Organization Classification of Tumours: Pathology and and Genetics
of Tumours of the Digestive System. IARC Press; Lyon, France:
2000
|
16
|
Leloup L and Wells A: Calpains as
potential anti-cancer targets. Expert Opin Ther Targets.
15:309–323. 2011. View Article : Google Scholar : PubMed/NCBI
|
17
|
Popp O, Heidinger M, Ruiz-Heinrich L, Ries
C, Jochum M and Gil-Parrado S: The calpastatin-derived calpain
inhibitor CP1B reduces mRNA expression of matrix
metalloproteinase-2 and −9 and invasion by leukemic THP-1 cells.
Biol Chem. 384:951–958. 2003. View Article : Google Scholar : PubMed/NCBI
|
18
|
Fan DG, Dai JY, Tang J, Wu MM, Sun SG,
Jiang JL and Fan QY: Silencing of calpain expression reduces the
metastatic potential of human osteosarcoma cells. Cell Biol Int.
33:1263–1267. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Carragher NO, Walker SM, Carragher LA
Scott, Harris F, Sawyer TK, Brunton VG, Ozanne BW and Frame MC:
Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid
modes of tumour cell invasion: A link to integrin function.
Oncogene. 25:5726–5740. 2006. View Article : Google Scholar : PubMed/NCBI
|
20
|
Choi YH, Lee SJ, Nguyen P, Jang JS, Lee J,
Wu ML, Takano E, Maki M, Henkart PA and Trepel JB: Regulation of
cyclin D1 by calpain protease. J Biol Chem. 272:28479–28484. 1997.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang XD, Rosales JL, Magliocco A,
Gnanakumar R and Lee KY: Cyclin E in breast tumors is cleaved into
its low molecular weight forms by calpain. Oncogene. 22:769–774.
2003. View Article : Google Scholar : PubMed/NCBI
|
22
|
Chen Z, Knutson E, Kurosky A and Albrecht
T: Degradation of p21cip1 in cells productively infected with human
cytomegalovirus. J Virol. 75:3613–3625. 2001. View Article : Google Scholar : PubMed/NCBI
|
23
|
Delmas C, Aragou N, Poussard S, Cottin P,
Darbon JM and Manenti S: MAP kinase-dependent degradation of
p27Kip1 by calpains in choroidal melanoma cells. Requirement of
p27Kip1 nuclear export. J Biol Chem. 278:12443–12451. 2003.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Atencio IA, Ramachandra M, Shabram P and
Demers GW: Calpain inhibitor 1 activates p53-dependent apoptosis in
tumor cell lines. Cell Growth Differ. 11:247–253. 2000.PubMed/NCBI
|
25
|
Del Bello B, Moretti D, Gamberucci A and
Maellaro E: Cross-talk between calpain and caspase-3/−7 in
cisplatin-induced apoptosis of melanoma cells: A major role of
calpain inhibition in cell death protection and p53 status.
Oncogene. 26:2717–2726. 2007. View Article : Google Scholar : PubMed/NCBI
|
26
|
Raynaud F and Marcilhac A: Implication of
calpain in neuronal apoptosis. A possible regulation of Alzheimer's
disease. FEBS J. 273:3437–3443. 2006. View Article : Google Scholar : PubMed/NCBI
|
27
|
Santos DM, Xavier JM, Morgado AL, Solá S
and Rodrigues CM: Distinct regulatory functions of calpain 1 and 2
during neural stem cell self-renewal and differentiation. PLoS One.
7:e334682012. View Article : Google Scholar : PubMed/NCBI
|